Drug Shortage Report for MOZOBIL
| Report ID | 125088 |
| Drug Identification Number | 02377225 |
| Brand name | MOZOBIL |
| Common or Proper name | Mozobil |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PLERIXAFOR |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 x 2.0ml |
| ATC code | L03AX |
| ATC description | IMMUNOSTIMULANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-12-04 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2020-11-25 |
| Shortage status | Avoided shortage |
| Updated date | 2020-11-25 |
| Company comments | production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.